Clinical significance of cadherin-6 expression in primary and recurrent epithelial ovarian cancer and its association with outcomes: A potential therapeutic target for epithelial ovarian cancer

被引：0
|
作者：
Shintani, Daisuke [1 ]
Hanaoka, Mieko [1 ]
Sato, Sho [1 ]
Yano, Mitutake [2 ]
Ogasawara, Aiko [1 ]
Kato, Tomomi [1 ]
Yabuno, Akira [1 ]
Yasuda, Masanori [2 ]
Kaneda, Yuki [3 ]
Nagata, Motoko [3 ]
Hasegawa, Kosei [1 ]
机构：
[1] Saitama Med Univ Int Med Ctr, Hidaka, Japan
[2] Daiichi Sankyo Co Ltd, Tokyo, Japan
[3] Daiichi Sankyo Co Ltd, Tokyo, Japan
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
206
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [1] Targeting cadherin-6 in epithelial ovarian cancer: Clinical significance of its expression and efficacy of raludotatug deruxtecan (R-DXd) in patient-derived cell models
    Shintani, D.
    Hanaoka, M.
    Kaneda, Y.
    Ogasawara, A.
    Yano, M.
    Katoh, T.
    Yasuda, M.
    Nagata, M.
    Hasegawa, K.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S525 - S526
  • [2] Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer
    Jin, Z.
    Gu, J.
    Xin, X.
    Li, Y.
    Wang, H.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (05) : 519 - 524
  • [3] Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance
    Wang, Li
    Ma, Jie
    Liu, FengHua
    Yu, QingKai
    Chu, GuangMin
    Perkins, Alan C.
    Li, Yong
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 105 (03) : 695 - 702
  • [4] Expression and clinical significance of BIRC6 in human epithelial ovarian cancer
    Wang, Lin
    Chen, Yan-Jie
    Hou, Jun
    Wang, Ya-Yun
    Tang, Wen-Qing
    Shen, Xi-Zhong
    Tu, Rui-Qin
    [J]. TUMOR BIOLOGY, 2014, 35 (05) : 4891 - 4896
  • [5] Expression of RRBP1 in epithelial ovarian cancer and its clinical significance
    Ma, Jing
    Ren, Sujing
    Ding, Jing
    Liu, Shuang
    Zhu, Jiaqi
    Ma, Rong
    Meng, Fanling
    [J]. BIOSCIENCE REPORTS, 2019, 39
  • [6] Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential
    Danhua Ruan
    Jirui Wen
    Fei Fang
    Yuqin Lei
    Zhiwei Zhao
    Yali Miao
    [J]. Cell Death Discovery, 9
  • [7] CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
    Feng, Xiaojie
    Bai, Xupeng
    Ni, Jie
    Wasinger, Valerie C.
    Beretov, Julia
    Zhu, Ying
    Graham, Peter
    Li, Yong
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [8] Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer
    Lee, Jeong-Won
    Ryu, Ji-Yoon
    Yoon, Gun
    Jeon, Hye-Kyung
    Cho, Young-Jae
    Choi, Jung-Joo
    Song, Sang Yong
    Do, In-Gu
    Lee, Yoo-Young
    Kim, Tae-Joong
    Choi, Chel Hun
    Kim, Byoung-Gie
    Bae, Duk-Soo
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (01) : 221 - 229
  • [9] Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential
    Ruan, Danhua
    Wen, Jirui
    Fang, Fei
    Lei, Yuqin
    Zhao, Zhiwei
    Miao, Yali
    [J]. CELL DEATH DISCOVERY, 2023, 9 (01)
  • [10] Clinical significance of ascites in epithelial ovarian cancer
    Huang, H.
    Li, Y. J.
    Lan, C. Y.
    Huang, Q. D.
    Feng, Y. L.
    Huang, Y. W.
    Liu, J. H.
    [J]. NEOPLASMA, 2013, 60 (05) : 546 - 552
12345